Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial
Author(s) -
Cristina Razquín,
Estefanía Toledo,
Clary B. Clish,
Miguel RuizCanela,
Courtney Dennis,
Dolores Corella,
Christopher Papandreou,
Emilio Ros,
Ramón Estruch,
Marta GuaschFerré,
Enrique GómezGracia,
Montserrat Fitó,
Edward Yu,
José Lapetra,
Dong Wang,
Dora Romaguera,
Liming Liang,
Ángel M. AlonsoGómez,
Amy Deik,
Mònica Bulló,
Lluís SerraMajem,
Jordi SalasSalvadó,
Frank B. Hu,
Miguel Ángel MartínezGonzález
Publication year - 2018
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc18-0840
Subject(s) - lipidome , medicine , type 2 diabetes , lipidomics , population , lipid profile , cohort , diabetes mellitus , lower risk , cholesterol , endocrinology , bioinformatics , confidence interval , lipid metabolism , biology , environmental health
Specific lipid molecular changes leading to type 2 diabetes (T2D) are largely unknown. We assessed lipidome factors associated with future occurrence of T2D in a population at high cardiovascular risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom